Literature DB >> 18619445

Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death.

Lauren E Holz1, Volker Benseler, David G Bowen, Philippe Bouillet, Andreas Strasser, Lorraine O'Reilly, William M H d'Avigdor, Alex G Bishop, Geoffrey W McCaughan, Patrick Bertolino.   

Abstract

BACKGROUND & AIMS: Chronic infections by hepatotropic viruses such as hepatitis B and C are generally associated with an impaired CD8 T-cell immune response that is unable to clear the virus. The liver is increasingly recognized as an alternative site in which primary activation of CD8 T cells takes place, a property that might explain its role in inducing tolerance. However, the molecular mechanism by which intrahepatically activated T cells become tolerant is unknown. Here, we investigated the phenotype and fate of naïve CD8 T cells activated by hepatocytes in vivo.
METHODS: Transgenic mouse models in which the antigen is expressed in lymph nodes and/or in the liver were adoptively transferred with naïve CD8 T cells specific for the hepatic antigen.
RESULTS: Liver-activated CD8 T cells displayed poor effector functions and a unique CD25(low) CD54(low) phenotype. This phenotype was associated with increased expression of the proapoptotic protein Bim and caspase-3, demonstrating that these cells are programmed to die following intrahepatic activation. Importantly, we show that T cells deficient for Bim survived following intrahepatic activation.
CONCLUSIONS: This study identifies Bim for the first time as a critical initiator of T-cell death in the liver. Thus, strategies inhibiting the up-regulation of this molecule could potentially be used to rescue CD8 T cells, clear the virus, and reverse the outcome of viral chronic infections affecting the liver.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18619445      PMCID: PMC2956118          DOI: 10.1053/j.gastro.2008.05.078

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  31 in total

1.  Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.

Authors:  P Bouillet; D Metcalf; D C Huang; D M Tarlinton; T W Kay; F Köntgen; J M Adams; A Strasser
Journal:  Science       Date:  1999-11-26       Impact factor: 47.728

Review 2.  Intrahepatic immunity: a tale of two sites?

Authors:  David G Bowen; Geoffrey W McCaughan; Patrick Bertolino
Journal:  Trends Immunol       Date:  2005-10       Impact factor: 16.687

3.  Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling.

Authors:  Karl S Lang; Panco Georgiev; Mike Recher; Alexander A Navarini; Andreas Bergthaler; Mathias Heikenwalder; Nicola L Harris; Tobias Junt; Bernhard Odermatt; Pierre-Alain Clavien; Hanspeter Pircher; Shizuo Akira; Hans Hengartner; Rolf M Zinkernagel
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

4.  T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells.

Authors:  Alessandra Warren; David G Le Couteur; Robin Fraser; David G Bowen; Geoffrey W McCaughan; Patrick Bertolino
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

5.  Induction of tolerance in CD8+ T cells to a transgenic autoantigen expressed in the liver does not require cross-presentation.

Authors:  Junko Morimoto; Xiaoxio Tan; Ryan M Teague; Claes Ohlén; Philip D Greenberg
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

Review 6.  Common gamma chain cytokines: dissidence in the details.

Authors:  Nuno L Alves; Fernando A Arosa; René A W van Lier
Journal:  Immunol Lett       Date:  2006-12-18       Impact factor: 3.685

7.  Antigen-specific primary activation of CD8+ T cells within the liver.

Authors:  P Bertolino; D G Bowen; G W McCaughan; B Fazekas de St Groth
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

8.  Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis.

Authors:  Katja Derkow; Christoph Loddenkemper; Justine Mintern; Nils Kruse; Katja Klugewitz; Thomas Berg; Bertram Wiedenmann; Hidde L Ploegh; Eckart Schott
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

Review 9.  The liver: a special case in transplantation tolerance.

Authors:  Volker Benseler; Geoffrey W McCaughan; Hans J Schlitt; G Alex Bishop; David G Bowen; Patrick Bertolino
Journal:  Semin Liver Dis       Date:  2007-05       Impact factor: 6.115

10.  Complete differentiation of CD8+ T cells activated locally within the transplanted liver.

Authors:  Ingo Klein; Ian Nicholas Crispe
Journal:  J Exp Med       Date:  2006-02-13       Impact factor: 14.307

View more
  42 in total

1.  Hepatocyte entry leads to degradation of autoreactive CD8 T cells.

Authors:  Volker Benseler; Alessandra Warren; Michelle Vo; Lauren E Holz; Szun S Tay; David G Le Couteur; Eamon Breen; Anthony C Allison; Nico van Rooijen; Claire McGuffog; Hans J Schlitt; David G Bowen; Geoffrey W McCaughan; Patrick Bertolino
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-20       Impact factor: 11.205

Review 2.  Antigen-presenting cell function in the tolerogenic liver environment.

Authors:  Angus W Thomson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-11       Impact factor: 53.106

3.  TLR9-Mediated Conditioning of Liver Environment Is Essential for Successful Intrahepatic Immunotherapy and Effective Memory Recall.

Authors:  Marcin Cebula; Mathias Riehn; Upneet Hillebrand; Ramona F Kratzer; Florian Kreppel; Georgia Koutsoumpli; Toos Daemen; Hansjörg Hauser; Dagmar Wirth
Journal:  Mol Ther       Date:  2017-07-14       Impact factor: 11.454

Review 4.  Living in the liver: hepatic infections.

Authors:  Ulrike Protzer; Mala K Maini; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2012-02-24       Impact factor: 53.106

Review 5.  The liver works as a school to educate regulatory immune cells.

Authors:  Fenglei Li; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-04-22       Impact factor: 11.530

6.  Antigen expression level threshold tunes the fate of CD8 T cells during primary hepatic immune responses.

Authors:  Szun Szun Tay; Yik Chun Wong; David M McDonald; Nicole A W Wood; Ben Roediger; Frederic Sierro; Claire Mcguffog; Ian E Alexander; G Alex Bishop; Jennifer R Gamble; Wolfgang Weninger; Geoffrey W McCaughan; Patrick Bertolino; David G Bowen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-10       Impact factor: 11.205

Review 7.  Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis.

Authors:  Muhammed Yüksel; Debby Laukens; Femke Heindryckx; Hans Van Vlierberghe; Anja Geerts; F Susan Wong; Li Wen; Isabelle Colle
Journal:  Int J Exp Pathol       Date:  2014-08-12       Impact factor: 1.925

8.  Liver is able to activate naïve CD8+ T cells with dysfunctional anti-viral activity in the murine system.

Authors:  John R Lukens; Joseph S Dolina; Taeg S Kim; Robert S Tacke; Young S Hahn
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

9.  Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.

Authors:  Sumaiya Chowdhury; Yiqian Chen; Tsun-Wen Yao; Katerina Ajami; Xin M Wang; Yury Popov; Detlef Schuppan; Patrick Bertolino; Geoffrey W McCaughan; Denise Mt Yu; Mark D Gorrell
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

Review 10.  Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.

Authors:  Elia Moreno-Cubero; Juan-Ramón Larrubia
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.